These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30348170)

  • 61. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre.
    Kerr T; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Zhang R; Wood E
    Int J Drug Policy; 2010 May; 21(3):255-8. PubMed ID: 19766474
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Developing a community-supported risk reduction intervention for syringe exchange registrants and their drug-free family or friends: a pilot study.
    Kidorf M; Latkin C; Brooner RK; Yan H; Peirce J
    J Addict Dis; 2021; 39(2):248-256. PubMed ID: 33287681
    [TBL] [Abstract][Full Text] [Related]  

  • 64. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
    Allen S; Ruiz M; O'Rourke A
    Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.
    Tesoriero JM; Battles HB; Klein SJ; Kaufman E; Birkhead GS
    J Am Pharm Assoc (2003); 2009; 49(3):407-16. PubMed ID: 19443321
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioid recovery initiation: Pilot test of a peer outreach and modified Recovery Management Checkup intervention for out-of-treatment opioid users.
    Scott CK; Grella CE; Nicholson L; Dennis ML
    J Subst Abuse Treat; 2018 Mar; 86():30-35. PubMed ID: 29415848
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study.
    Arribas-Ibar E; Sánchez-Niubò A; Majó X; Domingo-Salvany A; Brugal MT
    Harm Reduct J; 2014 Nov; 11(1):33. PubMed ID: 25416534
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Harm Reduction, By Mail: the Next Step in Promoting the Health of People Who Use Drugs.
    Hayes BT; Favaro J; Davis CS; Gonsalves GS; Beletsky L; Vlahov D; Heimer R; Fox AD
    J Urban Health; 2021 Aug; 98(4):532-537. PubMed ID: 33710493
    [No Abstract]   [Full Text] [Related]  

  • 70. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Merchants, samaritans, and public health workers: Secondary syringe exchanger discursive practices.
    Brothers S
    Int J Drug Policy; 2016 Nov; 37():1-8. PubMed ID: 27449813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Wu Q; Kamphuis C; Duo L; Luo J; Chen Y; Richardus JH
    Harm Reduct J; 2017 Feb; 14(1):10. PubMed ID: 28193236
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of a naloxone distribution and administration program in New York City.
    Piper TM; Stancliff S; Rudenstine S; Sherman S; Nandi V; Clear A; Galea S
    Subst Use Misuse; 2008; 43(7):858-70. PubMed ID: 18570021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City.
    Galea S; Worthington N; Piper TM; Nandi VV; Curtis M; Rosenthal DM
    Addict Behav; 2006 May; 31(5):907-12. PubMed ID: 16139434
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.
    Bastani P; Marshall BDL; Rahimi-Movaghar A; Noroozi A
    Int J Drug Policy; 2019 Jan; 63():90-96. PubMed ID: 30513474
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Commentary on Vickerman et al. (2012): Reducing hepatitis C virus among injection drug users through harm reduction programs.
    Smith-Spangler CM; Asch SM
    Addiction; 2012 Nov; 107(11):1996-7. PubMed ID: 23039752
    [No Abstract]   [Full Text] [Related]  

  • 79. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
    O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
    Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analytical findings in used syringes from a syringe exchange program.
    Fiorentin TR; Logan BK
    Int J Drug Policy; 2020 Jul; 81():102770. PubMed ID: 32442881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.